Showing results (311-320 of 324) with videos related to
Sort By:
Pageof 33
Journal of Medical Case Reports|March 24, 2023
Primary adrenal Ewing's sarcoma family of tumors with tumor thrombus of the inferior vena cava: a case reportKaya Atagi, Takashi Karashima, Keisuke Mizutani, et al.Journal of Hepato-Biliary-Pancreatic Sciences|March 24, 2025
Impact of the COVID-19 pandemic on the short-term outcomes after advanced liver resections performed in institutions certificated by Japanese Society of Hepato-Biliary-Pancreatic Surgery: Results from the Japanese National Clinical Database, 2018-2022Yusuke Takemura, Hideki Endo, Taizo Hibi, et al.Surgery Today|September 6, 2013
Report from the Committee for Improving the Work Environment of Japanese Surgeons: survey on effects of the fee revision for medical services provided by surgeonsKazuhiro Hanazaki, Ryuji Tominaga, Masaki Nio, et al.Annals of Surgery|October 11, 2019
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine TumorsJun Uemura, Keiichi Okano, Minoru Oshima, et al.Endocrine Journal|July 13, 2012
Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of JapanAkihiro Sakurai, Masanori Yamazaki, Shinichi Suzuki, et al.Oncotarget|September 26, 2018
Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancerTakahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, et al.Oncotarget|October 22, 2021
Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancerTakahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, et al.Surgery Today|August 10, 2022
Impact of the hospital volume and setting on postoperative complications of surgery for gastroenterological cancers in a regional area of Western JapanSusumu Kunisawa, Haku Ishida, Hiroshi Ikai, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 27, 2005
[Survey of gemcitabine treatment for advanced pancreatic cancer in 20 hospitals of Nagano Prefecture]Shinya Maejima, Nobumichi Takeuchi, Osamu Hasebe, et al.Molecular and Clinical Oncology|July 3, 2015
Feasibility of oral administration of S-1 as adjuvant chemotherapy in gastric cancer: 4-week S-1 administration followed by 2-week rest vs. 2-week administration followed by 1-week restTomoki Yamatsuji, Yasuhiro Fujiwara, Hideo Matsumoto, et al.Pageof 33